Ribosome-inactivating protein PD-L1/PD-L2 (47-77), IKY31

General Information


DRACP ID  DRACP03695

Peptide Name   Ribosome-inactivating protein PD-L1/PD-L2 (47-77), IKY31

Sequence  IKYLLVKLQGASQKTITLMLRRNNLYVMGYS

Sequence Length  31

UniProt ID  P84853 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C164H276N44O43S2

Absent amino acids  CDEFHPW

Common amino acids  L

Mass  415168

Pl  10.79

Basic residues  5

Acidic residues  0

Hydrophobic residues  11

Net charge  5

Boman Index  -2738

Hydrophobicity  10.97

Aliphatic Index  122.58

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  4470

Absorbance 280nm  149

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29684330

Title  Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L Evaluation of their antimicrobial properties and anti-biofilm activities

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11272

DRACP is developed by Dr.Zheng's team.